1. Home
  2. FFIC vs CRVS Comparison

FFIC vs CRVS Comparison

Compare FFIC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$15.03

Market Cap

557.3M

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$6.80

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
CRVS
Founded
1929
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
557.3M
546.7M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
FFIC
CRVS
Price
$15.03
$6.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$13.75
AVG Volume (30 Days)
503.3K
1.7M
Earning Date
01-27-2026
11-04-2025
Dividend Yield
5.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$143,853,000.00
N/A
Revenue This Year
$113.60
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$2.54
52 Week High
$17.79
$9.60

Technical Indicators

Market Signals
Indicator
FFIC
CRVS
Relative Strength Index (RSI) 38.28 36.31
Support Level $14.49 $6.45
Resistance Level $15.46 $7.18
Average True Range (ATR) 0.56 0.46
MACD -0.28 -0.08
Stochastic Oscillator 24.44 20.06

Price Performance

Historical Comparison
FFIC
CRVS

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: